Cargando…
Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
Clinical decision making is based on results from qualitative and quantitative information. To provide quantitative data, various laboratory variables are widely used in the clinical evaluation of patients with small-cell lung cancer (SCLC). The tumour marker serum neuron-specific enolase (S-NSE) an...
Autores principales: | Jørgensen, L. G., Osterlind, K., Hansen, H. H., Cooper, E. H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033420/ https://www.ncbi.nlm.nih.gov/pubmed/7917935 |
Ejemplares similares
-
Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC).
por: Jørgensen, L. G., et al.
Publicado: (1992) -
Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.
por: Jørgensen, L. G., et al.
Publicado: (1996) -
The prognostic influence of serum neuron specific enolase in small cell lung cancer.
por: Jørgensen, L. G., et al.
Publicado: (1988) -
Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres
Publicado: (1996) -
Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer.
por: Jørgensen, L. G., et al.
Publicado: (1991)